The Combined Usage of Clinical Physical Finding in Management of COVID 19 Patients
1 other identifier
observational
10,000
1 country
1
Brief Summary
Physiological indicators such as blood pressure, heart rate, respiratory rate, and consciousness status of COVID-19 patients are used to apply the START (simple triage and rapid treatment, START), Modified Early Warning Score (MEWS), and quick Sequential Organ Failure Assessment (qSOFA) as tools for assessing clinical symptom tracking, deterioration, and subsequent improvement in COVID-19 patients. In response to the need for scarce manpower when a large number of emergency patients appear, a simple and easy-to-operate assessment method is adopted for mild patients, and artificial intelligence technology can be further used to assist in the assessment for early response and medication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2024
CompletedFirst Submitted
Initial submission to the registry
July 29, 2024
CompletedFirst Posted
Study publicly available on registry
July 30, 2024
CompletedAugust 1, 2024
July 1, 2024
1.6 years
July 29, 2024
July 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
COVID 19 pandemic
Assessing clinical symptom tracking, deterioration, and subsequent improvement in COVID-19 patients.
March 2020 and September 2022
Interventions
Physiological indicators such as blood pressure, heart rate, respiratory rate, and consciousness status of COVID-19 patients are used to apply the START, MEWS, and qSOFA in COVID-19 patients.(COVID 19 病患).
Eligibility Criteria
COVID 19 patients were treated in the hospital between March 2020 and Sep.2022
You may qualify if:
- a group of hospitalized COVID 19 patients were treated in the hospital between March 2020 and Sep.2022
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Martin De Porres Hospital
Tainan, 60069, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chia-Hsi Chen, MD
St. Martin De Porres Hospital,emergency medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician of Emergency Medicine
Study Record Dates
First Submitted
July 29, 2024
First Posted
July 30, 2024
Study Start
September 30, 2020
Primary Completion
May 1, 2022
Study Completion
July 20, 2024
Last Updated
August 1, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share